Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Mesenchymal Stem Cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer.

Dwyer RM, Ryan J, Havelin RJ, Morris JC, Miller BW, Liu Z, Flavin R, O'Flatharta C, Foley MJ, Barrett HH, Murphy JM, Barry FP, O'Brien T, Kerin MJ.

Stem Cells. 2011 Jul;29(7):1149-57. doi: 10.1002/stem.665.

2.

Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery.

Knoop K, Kolokythas M, Klutz K, Willhauck MJ, Wunderlich N, Draganovici D, Zach C, Gildehaus FJ, Böning G, Göke B, Wagner E, Nelson PJ, Spitzweg C.

Mol Ther. 2011 Sep;19(9):1704-13. doi: 10.1038/mt.2011.93. Epub 2011 May 17.

3.

Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.

Knoop K, Schwenk N, Schmohl K, Müller A, Zach C, Cyran C, Carlsen J, Böning G, Bartenstein P, Göke B, Wagner E, Nelson PJ, Spitzweg C.

J Nucl Med. 2015 Apr;56(4):600-6. doi: 10.2967/jnumed.114.146662. Epub 2015 Mar 5.

4.

Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.

Knoop K, Schwenk N, Dolp P, Willhauck MJ, Zischek C, Zach C, Hacker M, Göke B, Wagner E, Nelson PJ, Spitzweg C.

Hum Gene Ther. 2013 Mar;24(3):306-16. doi: 10.1089/hum.2012.104.

5.

Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.

Kang JH, Chung JK, Lee YJ, Shin JH, Jeong JM, Lee DS, Lee MC.

J Nucl Med. 2004 Sep;45(9):1571-6.

6.

Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells.

Chai W, Yin X, Ren L, Cai M, Long T, Zhou M, Tang Y, Yang N, Hu S.

Clin Transl Oncol. 2015 Oct;17(10):795-802. doi: 10.1007/s12094-015-1307-x. Epub 2015 Jun 27.

PMID:
26115738
7.

Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking.

Kim YH, Lee DS, Kang JH, Lee YJ, Chung JK, Roh JK, Kim SU, Lee MC.

J Nucl Med. 2005 Feb;46(2):305-11.

8.

Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy.

Boland A, Ricard M, Opolon P, Bidart JM, Yeh P, Filetti S, Schlumberger M, Perricaudet M.

Cancer Res. 2000 Jul 1;60(13):3484-92.

9.

Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors.

Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC.

Hum Gene Ther. 2006 Jun;17(6):661-8.

PMID:
16776574
10.

Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter.

Kim SH, Chung HK, Kang JH, Kim KI, Jeon YH, Jin YN, Yun CO, Chung JK.

Hum Gene Ther. 2008 Sep;19(9):951-7. doi: 10.1089/hgt.2008.030.

PMID:
18810799
11.

Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene delivery.

Klutz K, Willhauck MJ, Wunderlich N, Zach C, Anton M, Senekowitsch-Schmidtke R, Göke B, Spitzweg C.

Hum Gene Ther. 2011 Nov;22(11):1403-12. doi: 10.1089/hum.2010.158. Epub 2011 Jun 28.

12.

In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter.

Shi S, Zhang M, Guo R, Miao Y, Hu J, Xi Y, Li B.

PLoS One. 2015 Jan 26;10(1):e0116531. doi: 10.1371/journal.pone.0116531. eCollection 2015.

13.

In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.

Dwyer RM, Bergert ER, O'connor MK, Gendler SJ, Morris JC.

Clin Cancer Res. 2005 Feb 15;11(4):1483-9.

14.

Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.

Petrich T, Helmeke HJ, Meyer GJ, Knapp WH, Pötter E.

Eur J Nucl Med Mol Imaging. 2002 Jul;29(7):842-54. Epub 2002 Apr 11.

PMID:
12111124
15.

Use of rhenium-188 for in vivo imaging and treatment of human cervical cancer cells transfected with lentivirus expressing sodium iodide symporter.

Zhang M, Shi S, Guo R, Miao Y, Li B.

Oncol Rep. 2016 Oct;36(4):2289-97. doi: 10.3892/or.2016.5034. Epub 2016 Aug 24.

PMID:
27573304
16.
17.

Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer.

Yao C, Pan Y, Li Y, Xu X, Lin Y, Wang W, Wang S.

Oncol Rep. 2015 Jul;34(1):59-66. doi: 10.3892/or.2015.3946. Epub 2015 May 5.

PMID:
25955347
18.

Trafficking macrophage migration using reporter gene imaging with human sodium iodide symporter in animal models of inflammation.

Seo JH, Jeon YH, Lee YJ, Yoon GS, Won DI, Ha JH, Jeong SY, Lee SW, Ahn BC, Lee J.

J Nucl Med. 2010 Oct;51(10):1637-43. doi: 10.2967/jnumed.110.077891. Epub 2010 Sep 16.

19.

Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter.

Huang R, Zhao Z, Ma X, Li S, Gong R, Kuang A.

Cancer Gene Ther. 2011 Feb;18(2):144-52. doi: 10.1038/cgt.2010.66. Epub 2010 Oct 29.

20.

Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.

Klutz K, Willhauck MJ, Dohmen C, Wunderlich N, Knoop K, Zach C, Senekowitsch-Schmidtke R, Gildehaus FJ, Ziegler S, Fürst S, Göke B, Wagner E, Ogris M, Spitzweg C.

Hum Gene Ther. 2011 Dec;22(12):1563-74. doi: 10.1089/hum.2011.041. Epub 2011 Oct 11.

Supplemental Content

Support Center